Key takeaways:
Combination inhalers often contain an inhaled corticosteroid (ICS) and long-acting beta agonist (LABA). A long-acting muscarinic antagonist (LAMA) may also be included.
Side effects vary based on what medications are in your inhaler. Oral thrush, voice changes, and sore throat are a few examples of steroid inhaler side effects. LABAs may cause muscle cramps and a faster heart rate. Dry mouth is a common LAMA side effect.
If you’re experiencing side effects from your combination inhaler, talk to a healthcare professional. They can help you manage these side effects and prevent them going forward.
If you’re living with a lung condition, such as asthma or chronic obstructive pulmonary disease (COPD), it’s important to have the right maintenance medications to manage your symptoms. Combination inhalers can be a convenient part of your treatment plan. They contain two or three different medications that work as a team in one device.
Combination inhalers often consist of an inhaled corticosteroid (ICS), a long-acting beta agonist (LABA), and/or a long-acting muscarinic antagonist (LAMA). ICS medications lower inflammation (swelling) in the airways of the lungs. LABAs and LAMAs are bronchodilators — meaning they open and relax the airways.
Common examples of combination inhalers include Advair (fluticasone / salmeterol), Anoro Ellipta (umeclidinium / vilanterol), and Trelegy Ellipta (fluticasone / umeclidinium / vilanterol). These types of combination inhalers are effective for many people. But like all medications, they have possible side effects to be aware of.
The side effects of combination inhalers are generally dose- and ingredient-related. This means that higher doses are more likely to cause side effects. Side effects may resolve after stopping the medication or lowering your dose.
Relatively common combination inhaler side effects include:
Oral thrush
Cough
Dysphonia (hoarseness)
Sore and dry throat
Dry mouth
Bitter taste
Skin bruises
Muscle cramps
Heart palpitations
Tremor
Increased appetite
Rare but serious side effects may include:
Pneumonia
Glaucoma
Cataracts
Adrenal insufficiency (adrenal glands don’t make enough of hormone cortisol)
Osteoporosis
Mood changes
New or worsening diabetes
Serious heart problems
Delayed growth in children
Many of these side effects are related to the steroid portion of combination inhalers. Thankfully, ICS side effects are usually less intense (and less likely) than the side effects of oral corticosteroids, such as prednisone.
COPD story: Hear one person’s experience living with chronic obstructive pulmonary disease (COPD) and how they manage it.
Trelegy Ellipta tips: Pharmacists share tips on how to use your Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) inhaler.
Side effect management: Learn from pharmacists about Symbicort (budesonide / formoterol) side effects and tips for managing them.
Below, we’ll cover 10 notable combination inhaler side effects in more detail.
Oral thrush is one of the most common steroid inhaler side effects. It’s not common to occur, however, when using a combination inhaler that doesn’t contain an ICS.
Thrush can look like white patches anywhere in the mouth and throat, including the tongue. It can make swallowing and eating painful. In one review of 16 studies, people using an ICS had an almost 3 times higher risk of getting thrush.
Rinsing your mouth with water and spitting it out after inhaling a dose can help lower the amount of steroid that remains in the mouth. In turn, this lowers the risk of thrush. If you have a metered-dose inhaler, spacers can also prevent thrush. Spacers help the medications reach your lungs rather than your mouth and throat.
If you do develop thrush, your healthcare professional may recommend an antifungal treatment to help treat the infection. Clotrimazole and nystatin are a couple of examples.
Hoarseness is another possible side effect of ICS-containing combination inhalers. This can happen if the medication affects your vocal cords. You may notice this within hours of inhaling your first dose, or it could develop months down the line. Thankfully, it’s generally short-lived.
Just like with oral thrush, prevention is key. Rinsing your mouth with water after using a steroid inhaler can lower the chance of experiencing hoarseness or voice changes.
You may develop a sore throat after administering a dose of your combination inhaler — especially if it contains an ICS. This isn’t typically a big issue. But rinsing your mouth after each inhaler dose and/or using a spacer can help prevent this from happening.
Dry mouth, or a dry throat, is a more common LAMA side effect. Umeclidinium is one example of a LAMA, which is found in combination inhalers like Anoro Ellipta and Trelegy Ellipta. Staying hydrated and chewing sugar-free gum are a couple of ways to manage dry mouth.
It can be unsettling to experience muscle cramps or spasms — especially if they wake you up in the middle of the night. But if your combination inhaler contains a LABA, that may be a culprit for why it’s happening.
LABAs are thought to activate beta receptors in the muscles, which may lead to cramps or spasms. One common LABA is formoterol, and it's found in inhalers such as Symbicort, Dulera, and Breztri Aerosphere.
In one small study, over 60% of people reported experiencing muscle cramps with LABAs. In the same study, muscle spasms (or “muscle twisting”) happened in nearly 40% of people. Thankfully, muscle-related side effects tend to improve when the LABA dose is lowered.
Shakiness, or tremors, can happen from the LABA portion of your combination inhaler. But it’s not common overall. In one review of over 8,500 people living with COPD, tremors occurred in less than 1% of people.
If you experience a tremor, it typically happens when you first start a LABA-containing combination inhaler. It usually gets better within a few days. If it doesn’t, reach out to your prescriber.
LABAs may speed up your heart rate. It’s more likely with high doses, and the risk to your heart might be higher within the first 30 days (1 month) of starting a LABA. That being said, studies of people with COPD have found that LABAs and LAMAs don’t cause long-term heart problems.
Still, if you have high blood pressure, heart failure, or any other heart problems, talk to a healthcare professional before starting a combination inhaler. They can help you weigh the pros and cons of these medications.
Pneumonia is a rare but serious steroid inhaler side effect. Corticosteroids can weaken your immune system, so they unintentionally increase the risk of infection.
The risk of pneumonia is greater with higher steroid doses. For instance, fluticasone doses greater than 500 mcg per day are considered to be on the higher end of the spectrum. People living with COPD who use ICS-containing combination inhalers may have a greater chance of developing pneumonia compared to those who use non-ICS medications. There may also be a higher risk with fluticasone compared to other steroids.
To reduce your risk of pneumonia, work with your prescriber to ensure you’re using the lowest effective steroid dose for your symptoms. Staying up to date on vaccines, including pneumonia and flu shots, can also help prevent infections. And if you ever develop pneumonia symptoms such as persistent cough, fever, or shortness of breath, report them to a healthcare professional right away.
Good to know: Cleaning your inhaler removes germs that build up in your inhaler device. This may help prevent infections too. But how you clean it depends on what type of inhaler you have. Reach out to your pharmacist to review cleaning instructions.
Adrenal insufficiency happens when your adrenal glands don’t produce enough of the hormones cortisol or aldosterone. ICS-containing inhalers can cause adrenal insufficiency if your body absorbs too much of the medication, reducing its natural cortisol production.
Adrenal insufficiency is rare with ICS combination inhalers. But it’s more likely with high doses used over a long period of time.
Reach out to your prescriber if you notice any symptoms of adrenal insufficiency. This may include muscle weakness, sudden stomach pain, or loss of appetite. They can check your cortisol levels with a blood test to see if you’re experiencing adrenal insufficiency.
Combination inhalers that contain an ICS may lower your bone density. Your bone density is a marker of how strong your bones are.
Some studies have shown a link between long-term ICS use and lower bone density. This can lead to a higher risk of fractures. The risk of bone fracture is greater with higher ICS doses, but it’s lower than with oral corticosteroids.
If you have any existing risk factors for osteoporosis — like a family history of osteoporosis or a medical condition that makes you unable to move — talk to a healthcare professional. They’ll review the risks and benefits of using a combination inhaler that contains an ICS.
Skin bruising occasionally happens with combination inhalers that contain an ICS. Multiple studies have linked long-term ICS inhaler use to bruising. It may be more likely to occur in older adults and people who use higher doses for a long period of time.
If you notice any abnormal bruising while using your combination inhaler, let your healthcare professional know.
Good to know: Keep a current list of your prescription and over-the-counter (OTC) medications handy. Your pharmacist and prescriber can check if any interactions could raise your risk of bruising or bleeding. One example is with anticoagulants such as Eliquis (apixaban).
It’s possible, but rare. Weight gain is more common with oral corticosteroids. Research shows that oral corticosteroids can increase appetite and promote fluid buildup. These factors can contribute to weight gain. Inhaled steroids don’t carry this same risk.
In some situations, yes. But many people with asthma and COPD benefit from indefinitely taking an ICS-containing combination inhaler. If your symptoms are well managed, you may be able to try a lower ICS dose. For instance, if your asthma is controlled well, your prescriber may lower your ICS dose by 25% to 50% every 3 months. Don’t stop or lower your inhaler dose without talking to a healthcare professional first.
Maybe. If you’re taking a high-dose ICS, you could theoretically develop Cushing’s syndrome (high cortisol levels). Symptoms may include moon face, bone pain, and muscle weakness. Reach out to your healthcare professional if you’re experiencing symptoms like these. Cushing’s syndrome is more likely to happen with oral corticosteroids.
It’s unlikely that steroid inhalers damage your lungs directly. But they can raise your risk of lung infections like pneumonia. Though it’s rare, pneumonia can cause long-term lung damage.
Combination inhalers often contain an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). A long-acting muscarinic antagonist (LAMA) may also be included. Each component of combination inhalers can cause side effects. Steroid inhaler side effects include oral thrush, bone fractures, and bruises. LABAs can cause side effects like muscle cramps, tremors, and a faster heart rate. Dry mouth is a common LAMA side effect. If you think you’re experiencing a side effect from your combination inhaler, talk to your prescriber for management tips.
American Lung Association. (2024). Pneumonia treatment and recovery.
American Lung Association. (2025). Asthma and COPD medicines.
Andreas, S. (2020). Effects of LAMA/LABA alone and in combination on cardiac safety. International Journal of Chronic Obstructive Pulmonary Disease.
Cazzola, M., et al. (2012). Tremor and B(2)-adrenergic agents: Is it a real clinical problem? Pulmonary Pharmacology & Therapeutics.
ConsumerMedSafety.org. (2024). Inhalers with steroids can cause temporary vocal cord damage. Institute for Safe Medication Practices.
Dahl, R. (2006). Systemic side effects of inhaled corticosteroids in patients with asthma. Respiratory Medicine.
Decramer, M. L., et al. (2013). The safety of long-acting β2 -agonists in the treatment of stable chronic obstructive pulmonary disease. International Journal of COPD.
Global Initiative for Asthma. (2024). Summary guide for asthma management and prevention for adults, adolescents, and children 6-11 years.
Global Initiative for Chronic Obstructive Lung Disease. (2025). 2025 GOLD report.
Guillot, B. (2000). Skin reactions to inhaled corticosteroids. Clinical aspects, incidence, avoidance, and management. American Journal of Clinical Dermatology.
Korsgaard, J., et al. (2009). Potential side effects in patients treated with inhaled corticosteroids and long-acting β2-agonists. Respiratory Medicine.
Loke, Y. K., et al. (2011) Risk of fractures with inhaled corticosteroids in COPD: Systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax.
MedlinePlus. (2023). Cushing syndrome.
Miravitlles, M., et al. (2021). Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review.
National Institute of Diabetes and Digestive and Kidney Diseases (2018). Symptoms & causes of adrenal insufficiency & Addison’s disease.
Sears, M. R. (2002). Adverse effects of β-agonists. The Journal of Allergy and Clinical Immunology.
Sibila, O., et al. (2016). The risk and outcomes of pneumonia in patients on inhaled corticosteroids. Pulmonary Pharmacology & Therapeutics.
Wang, M., et al. (2018). Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: A nested case-control study. JAMA Internal Medicine.
Yokoyama, H., et al. (2006). Influence of mouth washing procedures on the removal of drug residues following inhalation of corticosteroids. Biological and Pharmaceutical Bulletin.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.